[Systemic enzyme therapy of experimental gout glomerulonephritis].
Renal lesion deteriorates the course and prognosis of gouty glomerulonephritis. Current pathogenetic therapy is not sufficiently effective. Effects of different treatments on morphological and functional manifestations of renal disorders in experimental gouty glomerulonephritis are reviewed.
Ignatenko
G A
GA
Mukhin
I V
IV
D000818:Animals; D004195:Disease Models, Animal; D004338:Drug Combinations; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D006073:Gout / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006074:Gout Suppressants / Q000008:administration & dosage / Q000627:therapeutic use*; D006867:Hydrolases / Q000008:administration & dosage / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D008297:Male; D051381:Rats; D012431:Rutin / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D006074:Gout Suppressants; D012431:Rutin; C023295:Wobenzym; D006867:Hydrolases